Surgical outcomes after uterine artery occlusion at the time of myomectomy: systematic review and meta-analysis.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
04 2019
Historique:
received: 06 09 2018
revised: 10 11 2018
accepted: 11 12 2018
pubmed: 22 1 2019
medline: 3 8 2019
entrez: 22 1 2019
Statut: ppublish

Résumé

To systematically review and meta-analyze evidence on surgical outcomes after uterine artery occlusion (UAO) at myomectomy. Systematic review and meta-analysis. Not applicable. Twenty-six studies involving 2,871 patients located via database searches of MEDLINE, Embase, Web of Science, PubMed, clinicaltrials.gov, and cited references. Intervention groups undergoing UAO at laparoscopic or abdominal myomectomy (UAO+M) (1,569 patients), and control groups undergoing myomectomy alone (1,302 patients). Primary outcome of surgical blood loss (estimated blood loss, transfusion rate, and change in hemoglobin values), and secondary outcomes including operative time, length of stay, conversion and complications rates, fibroid recurrence, and changes in fibroid-related symptoms. The patients undergoing UAO+M had a statistically significant reduction in estimated blood loss (mean difference [MD] -103.7 mL; 95% confidence interval [CI], -126.5 to -80.8), blood transfusion (relative risk [RR] 0.24; 95% CI, 0.15-0.39), and change in hemoglobin values (MD -0.60 g/dL; 95% CI, -0.79 to -0.40) compared with controls. Using UAO+M prolonged operative times (MD 10.9 minutes; 95% CI, 3.5-18.2) but shortened the length of stay (MD -0.37 days; 95% CI, -0.62-0.11). Using UAO+M lowered the complication rates (RR 0.73; 95% CI, 0.52-1.00) to the threshold of statistical significance and reduced the risk of fibroid recurrence (RR 0.36; 95% CI, 0.16-0.83) compared with controls. Uterine artery occlusion at myomectomy is associated with decreased surgical blood loss and transfusion rate compared with control patients. However, further research is required on reproductive outcomes and the effect on ovarian reserve before routine use can be recommended in women desiring future fertility.

Identifiants

pubmed: 30661604
pii: S0015-0282(18)32297-0
doi: 10.1016/j.fertnstert.2018.12.011
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Pagination

816-827.e4

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Ari P Sanders (AP)

Department of Obstetrics and Gynecology, Mount Sinai Hospital and Women's College Hospital, and Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.

Wilson V Chan (WV)

Department of Obstetrics and Gynecology, University of Calgary, Calgary, Alberta, Canada.

Jennifer Tang (J)

Department of Obstetrics and Gynecology, Mount Sinai Hospital and Women's College Hospital, and Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.

Ally Murji (A)

Department of Obstetrics and Gynecology, Mount Sinai Hospital and Women's College Hospital, and Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada. Electronic address: ally.murji@sinaihealthsystem.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH